134 related articles for article (PubMed ID: 31018948)
1. Molecular Genetic Characterization of Acute Myeloid Leukemia With Trisomy 4 as the Sole Chromosome Abnormality.
Torkildsen S; Gorunova L; Heim S; Tjønnfjord GE; Spetalen S; Risberg B; Tran HTT; Panagopoulos I
Cancer Genomics Proteomics; 2019; 16(3):175-178. PubMed ID: 31018948
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic and clinical characterization of acute myeloid leukemia with trisomy 8 as the sole chromosome abnormality.
Liu J; Han W; Cai X; Wang Z; Cao L; Hua H; Jia Z; Chao H; Lu X; Shen H
Hematology; 2022 Dec; 27(1):565-574. PubMed ID: 35549661
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic characterization of acute myeloid leukemia with isolated trisomy of chromosomes 4, 11, and 21.
Zhou F; Shen H; Wang Z; Hua H; Wu P; Han W; Xia Jia Z; Cai X; Chao H; Lu X
Int J Lab Hematol; 2022 Apr; 44(2):356-363. PubMed ID: 34750981
[TBL] [Abstract][Full Text] [Related]
4. Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
Paschka P; Du J; Schlenk RF; Gaidzik VI; Bullinger L; Corbacioglu A; Späth D; Kayser S; Schlegelberger B; Krauter J; Ganser A; Köhne CH; Held G; von Lilienfeld-Toal M; Kirchen H; Rummel M; Götze K; Horst HA; Ringhoffer M; Lübbert M; Wattad M; Salih HR; Kündgen A; Döhner H; Döhner K
Blood; 2013 Jan; 121(1):170-7. PubMed ID: 23115274
[TBL] [Abstract][Full Text] [Related]
5. Molecular and clinicopathologic characterization of AML with isolated trisomy 4.
Bains A; Lu G; Yao H; Luthra R; Medeiros LJ; Sargent RL
Am J Clin Pathol; 2012 Mar; 137(3):387-94. PubMed ID: 22338050
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.
Herold T; Metzeler KH; Vosberg S; Hartmann L; Jurinovic V; Opatz S; Konstandin NP; Schneider S; Zellmeier E; Ksienzyk B; Graf A; Krebs S; Blum H; Cristina Sauerland M; Büchner T; Berdel WE; Wörmann BJ; Mansmann U; Hiddemann W; Bohlander SK; Spiekermann K; Greif PA
Genes Chromosomes Cancer; 2017 Jan; 56(1):75-86. PubMed ID: 27636548
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
[TBL] [Abstract][Full Text] [Related]
8. Association between structural and numerical chromosomal aberrations in acute myeloblastic leukemia: a study by RT-PCR and FISH in 447 patients with de-novo AML.
Krauter J; Ganser A; Bergmann L; Raghavachar A; Hoelzer D; Lübbert M; Schlimok G; Arnold R; Kirchner H; Port M; Heil G
Ann Hematol; 1999 Jun; 78(6):265-9. PubMed ID: 10422628
[TBL] [Abstract][Full Text] [Related]
9. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
[TBL] [Abstract][Full Text] [Related]
10. Trisomy 4 with double minute chromosomes in acute nonlymphocytic leukemia.
Thompson PW; Whittaker JA; Brennan H
Cancer Genet Cytogenet; 1993 Aug; 69(1):41-4. PubMed ID: 8374899
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21.
Bhatnagar B; Eisfeld AK; Kohlschmidt J; Mrózek K; Nicolet D; Papaioannou D; Walker CJ; Orwick S; Blachly JS; Kolitz JE; Powell BL; Carroll AJ; Stone RM; Byrd JC; Bloomfield CD
Leukemia; 2020 Feb; 34(2):358-368. PubMed ID: 31462731
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and clinical profiles of FLT3-ITD, FLT3-TKD, NPM1, C-KIT, DNMT3A, and CEBPA mutations in a cohort of patients with de novo acute myeloid leukemia from southwest China.
Gou H; Zhou J; Ye Y; Hu X; Shang M; Zhang J; Zhao Z; Peng W; Zhou Y; Zhou Y; Song X; Lu X; Ying B
Tumour Biol; 2016 Jun; 37(6):7357-70. PubMed ID: 26676635
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma with monosomy 13 developed in trisomy 13 acute myelocytic leukemia: numerical chromosome abnormality during chromosomal segregation process.
Sashida G; Ito Y; Nakajima A; Kawakubo K; Kuriyama Y; Yagasaki F; Bessho M; Ohyashiki K
Cancer Genet Cytogenet; 2003 Mar; 141(2):154-6. PubMed ID: 12606134
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations.
Devillier R; Gelsi-Boyer V; Brecqueville M; Carbuccia N; Murati A; Vey N; Birnbaum D; Mozziconacci MJ
Am J Hematol; 2012 Jul; 87(7):659-62. PubMed ID: 22535592
[TBL] [Abstract][Full Text] [Related]
15. Recurrent cytogenetic abnormalities observed in complete remission of acute myeloid leukemia do not necessarily mark preleukemic cells.
Raynaud SD; Brunet B; Chischportich M; Bayle J; Gratecos N; Pesce A; Dujardin P; Flandrin G; Ayraud N
Leukemia; 1994 Feb; 8(2):245-9. PubMed ID: 8309249
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia.
Berenstein R; Blau IW; Suckert N; Baldus C; Pezzutto A; Dörken B; Blau O
J Exp Clin Cancer Res; 2015 May; 34(1):55. PubMed ID: 25994761
[TBL] [Abstract][Full Text] [Related]
18. Gene mutational pattern and expression level in 560 acute myeloid leukemia patients and their clinical relevance.
Zhu YM; Wang PP; Huang JY; Chen YS; Chen B; Dai YJ; Yan H; Hu Y; Cheng WY; Ma TT; Chen SJ; Shen Y
J Transl Med; 2017 Aug; 15(1):178. PubMed ID: 28830460
[TBL] [Abstract][Full Text] [Related]
19. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY
Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248
[TBL] [Abstract][Full Text] [Related]
20. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
